Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Receivables (2020 - 2026)

Valneva SE (VALN) posted Receivables of $11.9 million for Q1 2026, down 63.36% sequentially from $32.4 million in Q4 2025, and down 66.36% YoY from $35.3 million in Q1 2025.

Analysis

Valneva SE (VALN) Receivables (2020 - 2026) Analysis & Trends

Valneva SE has reported Receivables for 7 years, with the latest figure at $11.9 million in Q1 2026.

  • Quarterly Receivables fell 66.36% year-over-year to $11.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.9 million (down 66.36% YoY) and the FY2025 annual result came in at $32.4 million, down 11.42% from the prior year.
  • Receivables fell to $11.9 million in Q1 2026 per VALN's latest filing, from $32.4 million in the prior quarter.
  • Over five years, Receivables peaked at $58.2 million in Q3 2022 and troughed at $197095.3 in Q2 2023.
  • A 5-year average of $30.1 million and a median of $29.6 million in 2024 frame the typical range for Receivables.
  • The sharpest annual moves came in 2023 and 2024: Receivables sank 98.86% in 2023, then soared 16612.1% in 2024.
  • Over 5 years, Receivables stood at $24.5 million in 2022, then soared by 76.66% to $43.3 million in 2023, then slipped by 16.57% to $36.1 million in 2024, then declined by 10.28% to $32.4 million in 2025, then sank by 63.36% to $11.9 million in 2026.
  • According to Business Quant data, Receivables over the past three periods registered $11.9 million, $32.4 million, and $23.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 215.33 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 18.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.99 Mn
Mar 31, 2026 11.86 Mn
Dec 31, 2025 32.38 Mn
Sep 30, 2025 23.47 Mn
Jun 30, 2025 27.31 Mn
Mar 31, 2025 35.26 Mn
Dec 31, 2024 37.62 Mn
Sep 30, 2024 33.34 Mn
Jun 30, 2024 32.94 Mn
Mar 31, 2024 29.64 Mn
Dec 31, 2023 44.88 Mn
Sep 30, 2023 48.27 Mn
Jun 30, 2023 36.80 Mn
Mar 31, 2023 29.00 Mn
Dec 31, 2022 24.48 Mn
Sep 30, 2022 58.21 Mn
Jun 30, 2022 17.34 Mn
Mar 31, 2022 28.13 Mn
Dec 31, 2021 50.37 Mn
Dec 31, 2020 22.94 Mn